Company: Arterial Light Science
Liaison(s): Marvin Prescott
Patients with chronic ischemia suffer from diminished blood flow to heart muscle. Conventional therapies are invasive, risky and have limited effectiveness. The student team is consulting with ALS to help develop and commercialize a wearable, non-invasive device designed to increase blood flow and grow new blood vessels in heart muscle. The device, known as the Cardio LaserPatch, has previously been shown to increase myocardial blood flow in rats, dogs, and pigs. The company is planning clinical trials and the KGI team is providing assistance in obtaining fast track FDA approval and in developing business and marketing plans.